Lumature Wealth Partners’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$117K Sell
2,075
-131
-6% -$7.21K 0.07% 186
2023
Q1
$119K Hold
2,206
0.07% 181
2022
Q4
$116K Sell
2,206
-812
-27% -$41.2K 0.06% 181
2022
Q3
$142K Buy
3,018
+56
+2% +$2.91K 0.08% 179
2022
Q2
$149K Hold
2,962
0.07% 189
2022
Q1
$181K Sell
2,962
-251
-8% -$15K 0.07% 183
2021
Q4
$212K Sell
3,213
-576
-15% -$36.9K 0.08% 140
2021
Q3
$238K Sell
3,789
-129
-3% -$8.23K 0.1% 128
2021
Q2
$236K Sell
3,918
-786
-17% -$45.5K 0.1% 125
2021
Q1
$259K Sell
4,704
-2,382
-34% -$132K 0.14% 108
2020
Q4
$387K Buy
+7,086
New +$370K 0.37% 83

Other funds holding IHI

Lumature Wealth Partners's IHI Position: Q2 2023 in Review

Lumature Wealth Partners reduced its iShares US Medical Devices ETF (IHI) stake by 5.9% in Q2 2023, selling an estimated $7.21K and leaving 2,075 shares worth $117K. The position accounts for 0.07% of the portfolio, ranked #186.

Lumature Wealth Partners first reported a position in IHI in Q4 2020 and has held it in 11 quarters since. The position peaked at $387K in Q4 2020. 585 funds tracked by Wall St. Rank hold IHI as of Q2 2023.

  • Lumature Wealth Partners held 2,075 shares of iShares US Medical Devices ETF worth $117K as of Q2 2023.
  • Lumature Wealth Partners sold 131 iShares US Medical Devices ETF shares in Q2 2023, an estimated $7.21K.
  • iShares US Medical Devices ETF made up 0.07% of Lumature Wealth Partners's portfolio in Q2 2023, its #186 holding.
  • Lumature Wealth Partners first reported a position in iShares US Medical Devices ETF in Q4 2020 and has held it in 11 quarters since.
  • Lumature Wealth Partners's iShares US Medical Devices ETF position peaked at $387K in Q4 2020.
  • 585 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2023.

Based on Lumature Wealth Partners's 13F filing for Q2 2023, filed 14 Aug 2023.